[HTML][HTML] 'Spikeopathy': COVID-19 spike protein is pathogenic, from both virus and vaccine mRNA

PI Parry, A Lefringhausen, C Turni, CJ Neil, R Cosford… - Biomedicines, 2023 - mdpi.com
The COVID-19 pandemic caused much illness, many deaths, and profound disruption to
society. The production of 'safe and effective'vaccines was a key public health target. Sadly …

[HTML][HTML] Cognitive impairment after long COVID-19: Current evidence and perspectives

Z Li, Z Zhang, Z Zhang, Z Wang, H Li - Frontiers in Neurology, 2023 - frontiersin.org
COVID-19, caused by the SARS-CoV-2 virus, is a respiratory infectious disease. While most
patients recover after treatment, there is growing evidence that COVID-19 may result in …

[HTML][HTML] SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells

N Huot, C Planchais, P Rosenbaum, V Contreras… - Nature …, 2023 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA generally becomes
undetectable in upper airways after a few days or weeks postinfection. Here we used a …

Challenges and opportunities in long COVID research

RE Hamlin, CA Blish - Immunity, 2024 - cell.com
Long COVID (LC) is a condition in which patients do not fully recover from the initial SARS-
CoV-2 infection but rather have persistent or new symptoms for months to years following …

Exploring the immunogenic properties of SARS-CoV-2 structural proteins: PAMP: TLR signaling in the mediation of the neuroinflammatory and neurologic sequelae of …

MG Frank, M Fleshner, SF Maier - Brain, Behavior, and Immunity, 2023 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) produces an array of
neurologic and neuropsychiatric symptoms in the acute and post-acute phase of infection …

[HTML][HTML] Clinical approach to post-acute sequelae after COVID-19 infection and vaccination

N Hulscher, BC Procter, C Wynn, PA McCullough - Cureus, 2023 - ncbi.nlm.nih.gov
The spike protein of SARS-CoV-2 has been found to exhibit pathogenic characteristics and
be a possible cause of post-acute sequelae after SARS-CoV-2 infection or COVID-19 …

[HTML][HTML] Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know

WM Zelek, RA Harrison - Immunobiology, 2023 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus was identified in
China in 2019 as the causative agent of COVID-19, and quickly spread throughout the …

[HTML][HTML] Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis

K Taylor, M Pearson, S Das, J Sardell… - Journal of Translational …, 2023 - Springer
Background Long COVID is a debilitating chronic condition that has affected over 100
million people globally. It is characterized by a diverse array of symptoms, including fatigue …

[HTML][HTML] Microstructural brain abnormalities, fatigue, and cognitive dysfunction after mild COVID-19

L Scardua-Silva, B Amorim da Costa… - Scientific Reports, 2024 - nature.com
Although some studies have shown neuroimaging and neuropsychological alterations in
post-COVID-19 patients, fewer combined neuroimaging and neuropsychology evaluations …

[HTML][HTML] COVID, complement, and the brain

SI Vlaicu, A Tatomir, J Cuevas, V Rus… - Frontiers in …, 2023 - frontiersin.org
The brains of COVID-19 patients are affected by the SARS-CoV-2 virus, and these effects
may contribute to several COVID-19 sequelae, including cognitive dysfunction (termed “long …